Digital TrendsLuxturna becomes first gene therapy approved to treat an inherited …Digital TrendsBiomedicine just took a giant step forward in the U.S. This week, the U.S. Food and Drug Administration approved Luxturna, a form of gene therapy that see… Continue reading
Next Big FutureCRISPR extends lifespan of Lou Gehrigs disease mice by 25%Next Big FutureThe therapy delayed the onset of the muscle wasting that characterizes the disease, which results in progressive weakness and eventually proves fatal when the muscl… Continue reading
Medical XpressGetting straight to the heart of the matter in stem cellsMedical XpressThe work, which appears in Genes & Development on December 21, 2017, offers scientists a streamlined method to arrive at functioning heart cells (cardiomyocytes) f… Continue reading
KSAT San AntonioHow stem cells can extend stroke treatment windowKSAT San AntonioShe was helicoptered to OHSU and the care of Wayne Clark, MD, Director, Oregon Stroke Center, Oregon Health & Science University. He asked if she wanted to be part of … Continue reading
First-in-Human Trial of New Immunotherapy Approach Shows Efficacy in Antibiotic ResistanceBusiness Wire (press release)“This study provides the first clinical evidence showing the human polyclonal antibody therapeutic–produced from our natural Diversit… Continue reading
|
CRISPR Applications Flourish in 2017 Despite Simmering IP Battle
GenomeWeb But the past few years have seen the discoveries of several new nucleases — most notably, the Broad Institute’s Feng Zhang’s bombshell revelation of Cpf1 in 2015 and Jennifer Doudna and Robert Tijan’s 2016 study on C2c2 (now called Cas13a). In the … |